Molecular mechanisms of zinc in prostate cancer;Zinek - molekulární mechanizmy u karcinomu prostaty

Klinicka Onkologie

Volumn 24, Issue 4, 2011, Pages 249-255

  Gumulec, J ^a   Masarik M ^a   Krizkova S ^d   Babula, P ^b   Hrabec, R ^c   Rovny A ^c   Masarikova M ^d   Kizek, René ^d  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d MENDEL UNIVERSITY IN BRNO   (Czech Republic)

Author keywords

Apoptosis; Glutathione; Metallothionein; Neoplasms; Prostate; Zinc

Indexed keywords

METALLOTHIONEIN; TUMOR MARKER; ZINC BINDING PROTEIN; ZINC ION; ZINC TRANSPORTER;

APOPTOSIS; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); INTRACELLULAR MEMBRANE; METASTASIS; MOLECULAR DYNAMICS; PATHOGENESIS; PROSTATE CANCER; REVIEW;

HUMANS; MALE; METALLOTHIONEIN; PROSTATIC NEOPLASMS; ZINC;

EID: 80052245132     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Wit RD, Sternberg CN. Cancers of the Genitourinary Tract. In: Cavalli F, Hansen HH, Kaye SB (eds). Textbook of medical oncology, Informa Healthcare. London: Dunitz 2009.
2. Kuroda N, Katto K, Tamura M et al. Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials. Med Mol Morphol 2010; 43(3): 165-169.
3. Študent V, Grepl M, Král M et al. Má vyšetření PSA stále význam při vyhledávání karcinomu prostaty? Urol pro Praxi 2006; 5(5): 214-218.
4. Jamaspishvili T, Kral M, Khomeriki I et al. Urine markers in monitoring for prostate cancer. Prostate Cancer Prostatic Dis 2010; 13(1): 12-19.
5. Habib FK. Evaluation of androgen metabolism studies in human prostate cancer - correlation with zinc levels. Prev Med 1980; 9(5): 650-656. (Pubitemid 10019195)
6. Andreini C, Banci L, Bertini I et al. Counting the zinc-proteins encoded in the human genome. J Proteome Res 2006; 5(1): 196-201. (Pubitemid 43100813)
7. Oteiza P, Mackenzie G. Zinc, oxidant-triggered cell signaling, and human health. Mol Aspects Med 2005; 26(4-5): 245-255. (Pubitemid 41226495)
8. Kambe T, Yamaguchi-Iwai Y, Sasaki R et al. Overview of mammalian zinc transporters. Cell Mol Life Sci 2004; 61(1): 49-68. (Pubitemid 38121899)
9. Colvin RA, Holmes WR, Fontaine CP et al. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2010; 2(5): 306-317.
10. Vallee B, Auld D. Short and long spacer sequences and other structural features of zinc binding sites in zinc enzymes. FEBS Lett 1989; 257(1): 138-140. (Pubitemid 19261780)
11. Maret W, Li Y. Coordination dynamics of zinc in proteins. Chem Rev 2009; 109(10): 4682-4707.
12. Hirano T, Murakami M, Fukada T et al. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol 2008; 97: 149-176. (Pubitemid 351697819)
13. Hogstrand C, Kille P, Nicholson RI et al. Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med 2009; 15(3): 101-111.
14. Yamasaki S, Sakata-Sogawa K, Hasegawa A et al. Zinc is a novel intracellular second messenger. J Cell Biol 2007; 177(4): 637-645. (Pubitemid 46799835)
15. Laity JH, Andrews GK. Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch Biochem Biophys 2007; 463(2): 201-210. (Pubitemid 47030338)
16. Costello L, Liu Y, Zou J et al. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 1999; 274(25): 17499-17504.
17. Coyle P, Philcox JC, Carey LC et al. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002; 59(4): 627-647.
18. Franklin RB, Milon B, Feng P et al. Zinc and zinc transporter in normal prostate function and the pathogenesis of prostate cancer. Front Biosci 2005; 10: 2230-2239. (Pubitemid 40905294)
19. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology Physiol Rev 1993; 73(1): 79-118.
20. Costello L, Franklin R. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5(1): 17.
21. Mycielska M, Patel A, Rizaner N et al. Citrate transport and metabolism in mammalian cells: prostate epithelial cells and prostate cancer. Bioessays 2009; 31(1): 10-20.
22. Medrano A, Fernández-Novell J, Ramió L et al. Utilization of citrate and lactate through a lactate dehydrogenase and ATP-regulated pathway in boar spermatozoa. Mol Reprod Dev 2006; 73(3): 369-378 (Pubitemid 43262052)
23. Costello L, Liu Y, Franklin R et al. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997; 272(46): 28875-28881. (Pubitemid 27498168)
24. Costello LC, Franklin RB. The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000; 59(4): 269-282.
25. Muntzing J, Varkarakis M, Saroff J et al. Comparison and significance of respiration and glycolysis of prostatic tissue from various species. J Med Primatol 1975; 4(4): 245-251.
26. Feng P, Liang JY, Li TL et al. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2000; 4(1): 31-36. (Pubitemid 30238686)
27. Feng P, Li T, Guan Z et al. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer 2008; 7(1): 25.
28. Jiang D, Sullivan P, Sensi S et al. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J Biol Chem 2001; 276(50): 47524-47529.
29. Franklin R, Ma J, Zou J et al. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003; 96(2-3): 435-442. (Pubitemid 36900381)
30. Golovine K, Makhov P, Uzzo R et al. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin Cancer Res 2008; 14(17): 5376-5384
31. Milon B C, Agyapong A, Bautista R et al. Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells. Prostate 2010; 70(3): 288-296.
32. Ray SK, Nishitani J, Petry MW et al. Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Mol Cell Biol 2003; 23(1): 259-271. (Pubitemid 36008519)
33. Thiagalingam A, De Bustros A, Borges M et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16(10): 5335-5345. (Pubitemid 26315052)
34. Gioeli D. Signal transduction in prostate cancer progression. Clin Sci 2005; 108(4): 293-308. (Pubitemid 40516993)
35. Taylor KM, Morgan HE, Smart K et al. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med 2007; 13(7-8): 396-406. (Pubitemid 47378142)
36. Hasumi M, Suzuki K, Matsui H et al. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 2003; 200(2): 187-195. (Pubitemid 38366101)
37. Modica-Napolitano JS, Singh KK. Mitochondrial dysfunction in cancer. Mitochondrion 2004; 4(5-6): 755-762.
38. Banas A, Kwiatek WM, Banas K et al. Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem 2010; 15(7): 1147-1155.
39. Tappel A. Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med Hypotheses 2007; 68(3): 562-564. (Pubitemid 46037986)
40. Sapota A, Darago A, Taczalski J et al. Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions. Biometals 2009; 22(6): 1041-1049.
41. Zachara BA, Szewczyk-Golec K, Wolski Z et al. Selenium level in benign and cancerous prostate. Biol Trace Elem Res 2005; 103(3): 199-206. (Pubitemid 40628895)
42. Kiziler AR, Aydemir B, Guzel S et al. May the level and ratio changes of trace elements be utilized in identification of disease progression and grade in prostatic cancer? J Trace Elem Electrolytes Health Dis 2010; 27(2): 65-72.
43. Kanoh W, Ohtani N, Mashiko T et al. Levels of alpha(2) macroglobulin can predict bone metastases in prostrate cancer. Anticancer Res 2001; 21(1 B): 551-556.
44. Guo JK, Deng WH, Zhang LC et al. Prediction of prostate cancer using hair trace element concentration and support vector machine method. Biol Trace Elem Res 2007; 116(3): 257-271.
45. Kizek R, Vacek J, Trnkova L et al. Využiti katalytických reakcí na rtut'ové elektrodě pro elektrochemické stanovení metalothioneinů. Chem Listy 2004; 98(4).
46. Eckschlager T, Adam V, Hrabeta J et al. Metallothioneins and cancer. Curr Protein Pept Sci 2009; 10(4): 360-375.
47. Krizkova S, Fabrik I, Adam V et al. Metallothionein - a promising tool for cancer diagnostics. Bratisl Lek Listy 2009; 110(2): 93-97.
48. Masarik M, Gumulec J, Kuchtickova S et al. Determination of novel tumor markers in prostate carcinoma. FEBS J 2010; 277(1): 188-188.
49. Gumulec J, Cernei NV, Zitka O et al. Zinc, Metallothionein and Prostate Tumour Cells - Is There Any Relation? 10th International Nutrition & Diagnostics Conference. Prague 2010.
50. Fabrik I, Adam V, Krizkova S et al. Level of heat-stable thiols in patients with a malignant tumor. Klin Onkol 2007; 20(6): 384-389. (Pubitemid 350273372)
51. Gumulec J, Masarik M, Hrabec R et al. Zinc and its relation to prostate tumous Prakt Lek 2010; 90(8): 455-459.
52. Kizek R, Vacek J, Adam V et al. Metallothionein - Cisplatine and anticancer therapy. Klin Biochem Metab 2004; 12(2): 72-78. (Pubitemid 38661207)
53. Petrlova J, Blastik O, Prusa R et al. Determination of metallothionein content in patients with breast cancer, colon cancer, and malignant melanoma. Klin Onkol 2006; 19(2): 138-142. (Pubitemid 44756664)
54. Zelena J, Potesil D, Vacek J et al. Metallothionein as a prognostic marker of tumor disease. Klin Onkol 2004, 17(6): 190-195. (Pubitemid 40066099)
55. Masarik M, Gumulec J, Kuchtickova S et al. Detection of metallothionein and alphamethylacyl CoA racemase as potential new markers for prostate carcinoma. Int J Mol Med 2009; 24 (Suppl 1): S48.